Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venugopal Gudipati

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Frontiers in Bioengineering and Biotechnology|March 3, 2020
Getting CD19 Into Shape: Expression of Natively Folded "Difficult-to- Express" CD19 for Staining and Stimulation of CAR-T CellsElisabeth Lobner, Anna Wachernig, Venugopal Gudipati, et al.
The FEBS Journal|August 22, 2014
Collapse of the native structure caused by a single amino acid exchange in human NAD(P)H:quinone oxidoreductase(1.)Wolf-Dieter Lienhart, Venugopal Gudipati, Michael K Uhl, et al.
The Journal of Organic Chemistry|December 19, 2019
Diastereoselective FeCl<sub>3</sub>·6H<sub>2</sub>O/NaBH<sub>4</sub> Reduction of Oxime Ether for the Synthesis of β-Lactamase Inhibitor RelebactamJohn Y L Chung, Dongfang Meng, Michael Shevlin, et al.
Frontiers in Immunology|July 1, 2021
Characterization of CD8 T Cell-Mediated Mutations in the Immunodominant Epitope GP33-41 of Lymphocytic Choriomeningitis VirusMark Smyth, Kseniya Khamina, Alexandra Popa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2022
EBAG9 silencing exerts an immune checkpoint function without aggravating adverse effectsAnthea Wirges, Mario Bunse, Jara J Joedicke, et al.
The FEBS Journal|February 26, 2017
Catalytic competence, structure and stability of the cancer-associated R139W variant of the human NAD(P)H:quinone oxidoreductase 1 (NQO1)Wolf-Dieter Lienhart, Emilia Strandback, Venugopal Gudipati, et al.
Nature Immunology|July 8, 2020
Inefficient CAR-proximal signaling blunts antigen sensitivityVenugopal Gudipati, Julian Rydzek, Iago Doel-Perez, et al.
Frontiers in Medicine|March 4, 2022
SARS-CoV-2-Specific Antibody (Ab) Levels and the Kinetic of Ab Decline Determine Ab Persistence Over 1 YearErika Garner-Spitzer, Angelika Wagner, Michael Kundi, et al.
Frontiers in Immunology|July 9, 2024
CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myelomaMichael W Moles, Henry Erdlei, Lutz Menzel, et al.
Journal for Immunotherapy of Cancer|February 28, 2024
CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulationJiri Eitler, Wiebke Rackwitz, Natalie Wotschel, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Frontiers in Bioengineering and Biotechnology|March 3, 2020
Getting CD19 Into Shape: Expression of Natively Folded "Difficult-to- Express" CD19 for Staining and Stimulation of CAR-T CellsElisabeth Lobner, Anna Wachernig, Venugopal Gudipati, et al.
The FEBS Journal|August 22, 2014
Collapse of the native structure caused by a single amino acid exchange in human NAD(P)H:quinone oxidoreductase(1.)Wolf-Dieter Lienhart, Venugopal Gudipati, Michael K Uhl, et al.
The Journal of Organic Chemistry|December 19, 2019
Diastereoselective FeCl<sub>3</sub>·6H<sub>2</sub>O/NaBH<sub>4</sub> Reduction of Oxime Ether for the Synthesis of β-Lactamase Inhibitor RelebactamJohn Y L Chung, Dongfang Meng, Michael Shevlin, et al.
Frontiers in Immunology|July 1, 2021
Characterization of CD8 T Cell-Mediated Mutations in the Immunodominant Epitope GP33-41 of Lymphocytic Choriomeningitis VirusMark Smyth, Kseniya Khamina, Alexandra Popa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2022
EBAG9 silencing exerts an immune checkpoint function without aggravating adverse effectsAnthea Wirges, Mario Bunse, Jara J Joedicke, et al.
The FEBS Journal|February 26, 2017
Catalytic competence, structure and stability of the cancer-associated R139W variant of the human NAD(P)H:quinone oxidoreductase 1 (NQO1)Wolf-Dieter Lienhart, Emilia Strandback, Venugopal Gudipati, et al.
Nature Immunology|July 8, 2020
Inefficient CAR-proximal signaling blunts antigen sensitivityVenugopal Gudipati, Julian Rydzek, Iago Doel-Perez, et al.
Frontiers in Medicine|March 4, 2022
SARS-CoV-2-Specific Antibody (Ab) Levels and the Kinetic of Ab Decline Determine Ab Persistence Over 1 YearErika Garner-Spitzer, Angelika Wagner, Michael Kundi, et al.
Frontiers in Immunology|July 9, 2024
CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myelomaMichael W Moles, Henry Erdlei, Lutz Menzel, et al.
Journal for Immunotherapy of Cancer|February 28, 2024
CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulationJiri Eitler, Wiebke Rackwitz, Natalie Wotschel, et al.
Pageof 3